• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TEOXANE SA TEOSYAL RHA 2; IMPLANT, DERMAL, FOR AESTHETIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TEOXANE SA TEOSYAL RHA 2; IMPLANT, DERMAL, FOR AESTHETIC USE Back to Search Results
Model Number RHA® 2 (1ML)
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Output Problem (3005)
Patient Problem Foreign Body Embolism (4439)
Event Date 11/18/2021
Event Type  Injury  
Manufacturer Narrative
Vascular complications are rare serious side effects, although widely known and documented in the context of filler injections.They are related to the accidental injection of the product inside or close to a blood vessel, leading to its occlusion or compression, blocking the blood flow.If treated on time with an appropriate treatment, symptoms can be fully resolved without sequelae.If the vascular complication is not detected/diagnosed and treated timely, it can lead to a skin necrosis.The risk of such adverse reactions is mentioned in the instructions for use of teosyal products.
 
Event Description
This case occurred in the united states.According to the information received on 24-nov-2021, a patient was injected on (b)(6) 2021 with a rha 2 product to the forehead.On an unknown exact date, between (b)(6) 2021, the patient presented with a vascular occlusion.Additionally, the physician noticed black and pink discoloration as well as some blistered looking tissue, from the middle third of her forehead going up to the hairline.As corrective treatments, the patient received antibiotics and steroids.At the time of this report, the events remained on going and no additional information was available.
 
Event Description
This case occurred in the united states.According to the information received on 24-nov-2021, a patient was injected on (b)(6) 2021 with a rha 2 product to the forehead.On an unknown exact date, between (b)(6) 2021 and 21-nov-2021, the patient presented with a vascular occlusion.Additionally, the physician noticed black and pink discoloration as well as some blistered looking tissue, from the middle third of her forehead going up to the hairline.As corrective treatments, the patient received antibiotics and steroids.As corrective treatments, the patient received antibiotics and steroids.Despite several attempts to follow up, no further information could be obtained.
 
Manufacturer Narrative
Vascular complications are rare serious side effects, although widely known and documented in the context of filler injections.They are related to the accidental injection of the product inside or close to a blood vessel, leading to its occlusion or compression, blocking the blood flow.If treated on time with an appropriate treatment, symptoms can be fully resolved without sequelae.If the vascular complication is not detected/diagnosed and treated timely, it can lead to a skin necrosis.The risk of such adverse reactions is mentioned in the instructions for use of teosyal products.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TEOSYAL RHA 2
Type of Device
IMPLANT, DERMAL, FOR AESTHETIC USE
Manufacturer (Section D)
TEOXANE SA
105 rue de lyon
geneva, 1203
SZ  1203
Manufacturer Contact
ornella fauconnot
105 rue de lyon
geneva, 1203
SZ   1203
MDR Report Key13078064
MDR Text Key284705243
Report Number3005975625-2021-00714
Device Sequence Number1
Product Code LMH
UDI-Device Identifier07640173230021
UDI-Public07640173230021
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P170002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/23/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/23/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberRHA® 2 (1ML)
Device Catalogue Number940007
Device Lot NumberTP30L-210916B0
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/24/2021
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient SexFemale
-
-